A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study
Keyword(s):
Phase 2
◽
2015 ◽
Vol 16
(16)
◽
pp. 1700-1710
◽
2020 ◽